Abstract-Loperamide, an effective antidiarrheal agent, was investigated in attempts to determine the site of action which underlies the antiperistaltic and other antidiarrheal actions. In in vitro studies, this compound applied in a dose over 10-8 g/ml, inhibited the release of both acetylcholine and prostaglandins during circumferential distension of the intestinal wall, in a dose dependent manner.
plexus. The inhibition of prostaglandin release may be due to inhibition of prostaglandin synthesis in the intestine because loperamide prevented the biosynthesis of prostaglandin from arachidonic acid. Although a high concentration of loperamide (10-6 g/ml) inhibited the contraction of the intestine to acetylcholine, this compound inhibited the contraction to nicotine and serotonin at a concentration which had no effect on the contraction to acetylcholine.
Thus loperamide apparently inhibits the peristaltic movement principally by reducing the release of acetylcholine and prostaglandin, at least during circumferential distension of the intestinal wall in vitro. The finding that loperamide inhibited the biosynthesis of prostaglandin may lead to elucidation of the mechanism of its antidiarrheal activity.
Loperamide has been demonstrated to be a specific and safe antidiarrheal agent. It has a wide margin of safety and exhibits antidiarrheal effect without opiate-like central nervous effects (1, 2, 3) . Pelemans and Vantrappen (4) reported that the efficacy of the drug could be demonstrated in patients with `functional' diarrhea due to an irritable colon as well as in patients with diarrhea as the result of organic lesions. A diarrhea induced by prostaglandin E1 was also prevented by loperamide (5). The pharmacology of loperamide differs significantly from that of other agents in that it acts locally to control diarrhea. The mechanism of action has not, however, been fully elucidated.
Many authors have shown that loperamide inhibits peristaltic activity in vitro (6, 7) and in vivo (8, 9). Van Nueten et al. (6) suggested that the drug interacts with both choli nergic and non-cholinergic mechanisms involved in peristaltic activity. Inhibition of the peristaltic reflex by the drug can be reversed partially by prostaglandin E (10) which is con sidered to modulate the activity of the cholinergic nervous system in the myenteric plexus (11, 12) . Recently, release of acetylcholine (ACh) (13, 14) and prostaglandins (15) has been demonstrated during the distension of the intestinal wall and the importance of these agents in the peristalsis was discussed.
Distension of the intestinal wall is also known to stimulate the myenteric plexus of the small intestine (16, 17).
The possibility that loperamide induces a decrease in the ACh release from nerves involved in peristalsis was investigated herein.
MATERIALS AND METHODS
Male guinea pigs weighing 500 to 700 g were used. Four to eight segments of the intestine about 5 cm long were excised from the distal part of the small intestine, excluding the most distal 10 cm portion, and weighed after blotting both sides of the wall with filter paper. These preparations were preserved in Tyrode solution for 20 min at room temper ature and then for 15 min in ice cold Tyrode solution with precautions for prevent possible existence of free ACh which could be released during preparation of the gut segments. The segments were then transferred to 5 PAM eserine containing Tyrode solution and incubated separately in organic baths containing 7 to 10 ml oxygenated solution at 38"C for 10 min under any one of the procedures described below.
The procedures tested were-a) Distension in circumferential direction (C): The segment was distended by inserting a glass rod of proper diameter, usually 7 mm, into the intestinal lumen and then incubation was carried out in the presence or absence of loperamide. b) Undistension (N): The segment was incubated without any treatment such as distension in the presence or absence of loperamide. In the experiments with loperamide, the intestinal segments which had been pretreated with the drug for 10 min during the period of ice cold preservation were used because the maximal effects of the drug to the intestinal movement were obtained a few minutes after application of the drug (6) while the effect of distension on the ACh release was evident within 30 sec (18). At the end of experiments, the bathing solution was collected and tested for ACh and prostaglandin-like activity.
Assay of ACh
The collected bath fluid was gently shaken with one tenth volume of Amberlite XAD-2 
Assay of pi ostaglandins
Prostaglandin in collected bath fluid was assayed on a rat fundus strip (20) suspended in oxygenated Tyrode solution at 37°C. To increase the specificity of the preparation to prostaglandin, hyoscine, phenoxybenzamine, pyrilamine (0.1 tg/ml in each case), inderal 2 ,ug/ml and methysergide 10 ng/ml were added to the Tyrode solution. The contractions of the fundus strip to the bath fluid were compared with those of known standard doses of prostaglandin E2. The amount of released prostaglandins was expressed as ng prostaglandin E2 equivalent/g tissue/min, although the bath fluid contained prostaglandin E2 and F2a as shown below. When the intestinal segment was exposed to drugs such as loperamide or naloxone, the bath fluids were compared with standard prostaglandin solutions to which the drugs concerned were added to give the same final concentration in the assay bath.
In some experiments, dried bath fluid was dissolved in ether and subjected to thin layer chromatography on silica gel G containing 3 per cent silver nitrate, as described by Bennett et al (21). The All solvent system of Green and Samuelsson (22) was used as the developing solvent. Authentic prostaglandin E1, E2 and F2a were treated similarly and chromatogra phed concurrently. Centimeter bands of the plates were then extracted with 1 ml of 50 per cent chloroform in methanol. After separation from solid matter, the solvent was evaporated at a temperature below 30'C and the residue was shaken with 1 ml of Tyrode solution for biological assay. As a result, the prostaglandin-like substance in the bath fluid was identified as prostaglandin E2 and F2a. 
RESULTS

Inhibition of ACh release
Treatment of the guinea pig ileum with loperamide inhibited the ACh output during the resting state. The extent of reduction of ACh release depended on the concentration of loperamide; by 10-8 g/ml loperamide the release of ACh was reduced from 9.0±0.9 to 6.9±0.7 ng/g/min (mean±S.E.), by 10-7 g/ml to 4.7±0.5 and by 10-6 g/ml to 4.2±0.8 ng/ g/min, respectively. In a previous paper (18) it was shown that the release of ACh from the intestine was significantly increased by circumferential distension of the intestinal wall.
The ACh release induced by distension was also reduced in the presence of loperamide in a concentration-dependent manner. This release was reduced by (10-8, 10-7 and 10-6 g/ml)
loperamide from 20.1-L-1.8 to 13.7±1.1, 10.8-1-0.8 and 8.14-1.2 ng/g/min, respectively (Fig. 1) . 
Inhibition of prostaglandin release
When the intestinal segments were distended circumferentially, the release of prostagl andin into the bathing fluid was enhanced from 1.7±0.1 ng/g/min at rest to 7.0±0.3 ng/g/ min. When loperamide was added to the medium in the concentration of 10-$, 10-1 and 10-6 g/ml, the prostaglandin release during distension was reduced to 6.2±0.3, 5.2+0.4 and 5.0+0.4 ng/g/min respectively, while the release during the resting state was only slightly reduced (Fig. 2) .
Effect of loperamide in the presence of naloxone
Recently, Mackerer et al (9) concluded that loperamide binds to opiate receptor sites in the myenteric plexus of the small intestine. If so, it is conceivable that loperamide exhibited the above mentioned effects by interacting with opiate receptors. In order to examine this possibility, the intestinal segments were pretreated with 10-8 g/ml naloxone for 15 min under ice cold condition and then used for the experiments. The experiments were carried out in the presence of naloxone. In these cases, the inhibitory effects of loperamide on the distension-induced release of ACh were not observed (Fig. 3A) . This concentration of naloxone applied alone had no effect on A.Ch release, but 10-q g/ml of naloxone increased the release. Increased liberation of ACh from isolated intestine by naloxone has also been shown by Waterfield and Kosterlitz (24) but the effective concen tration of naloxone in their work was somewhat lower (3.3 x 10-8 g/ml).
The inhibitory effect of the loperamide on the distension-induced release of prostaglandin on the other hand, was not affected by naloxone (Fig. 3B) . 
Inhibition of prostaglandin biosynthesis by loperamide
With no pre-incubation period, loperamide inhibited prostaglandin biosynthesis as illustrated in Fig. 4 . The inhibition was 19.0±8.5 and 44.8±4.0% at 10-1 and 10-6 g/ ml loperamide respectively.
Effect of loperamide on the response of the Hewn to spasmogenic drugs
The responses of the longitudinal muscle strips of guinea pig ileum to the three agonists, ACh, nicotine and serotonin, were studied by recording the isotonic contraction of the preparations before and after treatment with loperamide. After control responses had been obtained, loperamide was added to the bathing solution and was contacted with tissue for at least 10 min. Thereafter the contractions to each agonist were repeated in the presence of loperamide. A concentration of 0.1 pg/ml loperamide considerably reduced nicotine induced contractions of ileum and less intensely those to serotonin. This concentration of loperamide had no effect on the contraction to ACh (Table 1, Fig. 5 ). Addition of PGE2
(1 ng/ml) in the presence of loperamide partly restored the responses to nicotine and serotonin. Contraction to ACh was slightly enhanced by PGE2. High concentration of loperamide (10-6 g/ml) inhibited the contraction of longitudinal muscle strip to ACh, suggesting that loperamide acts directly on the smooth muscle. Thus, the drug seems to act both on nervous elements and on smooth muscle itself, at high con centrations. No doubt, peristalsis can be prevented by inhibiting contraction of smooth muscle. The effect of loperamide on smooth muscle, however, is assumed to be less im portant than that on the nervous activity, regarding the effect of this compound on peristaltic movement. The concentration of loperamide required to inhibit the contraction to ACh (direct effect) was more than 100 times higher than that required to reduce the distension induced release of ACh (effect on the nervous activity). There was no great discrepancy between the concentration of loperamide required to inhibit the nervous activity and that required to produce a sustained inhibition of the peristaltic activity in guinea pig ileum (6).
Concerning the mechanism of reversal of loperamide inhibition on serotonin and nicotine-induced contractions of guinea pig ileum by PGE2, two sites of action of PG can be considered; a neurotropic one in the myenteric plexus and musculotropic one on the smooth muscle. Actually PGE2 as low as 5 ng/ml increased the release of ACh from the isolated small intestine induced by nicotine or serotonin (12). PGE2 seems, however, unlikely to be concerned only with recovery of the neuronal release of ACh since responses to ACh were slightly enhanced in the presence of loperamide by PGE2 (from 93 to 114% of control as shown in Table 1 ), and because PGE2 itself enhanced the contractions to ACh (25, 26). Therefore, the effect of PGE2 may be related both to an increased ACh release and sensitizing action on smooth muscle.
The antidiarrheal activity of loperamide could be partly explained by its effect on peristalsis. The observation, however, that atropine which is most effective in reducing peristalsis is not an effective antidiarrheal drug (27) suggests that inhibition of peristaltic activity alone is not sufficient to prevent diarrhea. Although diarrhea related mechanisms 
